Summarized by Masters of Longevity from Longevity Technology.
Sironax reports ~50% enrollment in a Phase 2 trial testing SIR4156 with semaglutide.
Key Takeaways
- SIR4156 is being tested alongside semaglutide to preserve lean muscle.
- Mouse studies showed SIR4156 restored NAD+ and reduced muscle atrophy.
- Human safety and efficacy remain unproven and are not established.
